GPT and metabolic dysfunction-associated steatotic liver disease: miR-34a was superior to multiple clinical biomarkers (ALT, CK-18, FIB-4 score and AST to platelet ratio index, APRI) in diagnosing NAFLD (AUROC 0.811).